Jamjoom Pharmaceuticals Factory Company (4015.SR) SAU

143.10

-0.4(-0.28%)

Updated at December 25 01:59PM

Currency In SAR

Valuation

Market Cap10.65B
Enterprise Value10.39B
P/E Ratio22.41
PEG Ratio8.73
Price/Sales Ratio6.89
Price/Book Ratio6.07
Enterprise/Revenue6.77
Enterprise/EBITDA19.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.31
Operating Margin0.31

Management Effectiveness

Return On Assets0.22
Return On Equity0.28

Income Statement

Revenue1.32B
Revenue/Share20.8
Gross Profit820.5M
EBITDA420.17M
Net Income356.52M
Diluted EPS5.1

Balance Sheet

Total Cash169.7M
Total Cash/Share2.42
Total Debt4.08M
Total Debt/Equity0
Current Ratio4.18
Book Value Per Share23.61

Price History

52-Week Change-9.02
52-Week High183.8
52-Week Low134
Moving Average 50 Days149.95
Moving Average 200 Days159.01

Statistics

Average Volume55,573
Shares Outstanding70M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.46
Trailing Annual Dividend Yield2.42
Payout Ratio0.54
Last Split FactorN/A
Last Split DateN/A